DUBLIN, Feb. 28, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/xd4dc6/cancer_test) has announced the addition of the "Concise Analysis of the International Cancer Test Market" report to their offering.
Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians.
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018.
This study provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters.
Key Topics Covered:
Table of Contents
1. Executive Summary
2. Global - Cancer Testing Market and New Cases
3. Global - Cancer Testing Market Share
4. Global - Segment Wise Cancer Testing Market
5. Global - Organ Specific Cancer Testing Market
6. Cancer Diagnostics- Companies Novel Test Platforms & Pipeline Analysis (20 Companies Analysis)
- BD Diagnostics
- Beckman Coulter
- Genomic Health
- Myriad Genetics
- Panacea Pharmaceuticals
- QIAGEN Marseille (Earlier Ipsogen)
- Radient Pharmaceuticals
- Siemens Heathcare Diagnostics
- Ventana Medical Systems
For more information visit http://www.researchandmarkets.com/research/xd4dc6/cancer_test
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets